Drawing for HEALORA

USPTO serial 99091416

HEALORA

Reviewed by CopyMark Law Group

Status 802
Filing date
Status date
Registration date
—
Examiner
HARRIS, SIERRA DOMINIQUE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with HEALORA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Medical instruments, namely, orthopedic apparatus and instruments; Surgical apparatus and instruments for medical use; Medical apparatus and instruments for treating cardiovascular disease; Medical apparatus and instruments for diagnostic radiopharmaceutical use; Medical apparatus and instruments relating to neurovegetative reactivity; Medical apparatus and instruments for use in surgery; Medical apparatus and instruments for treating osteoarthritis and osteoporosis; Medical instrument for cardiovascular diagnostics; Medical instrument organizer specially fitted with pockets adapted for holding medical instruments; Medical device and surgical instrument for use in diagnosis and surgery of the gastro-intestinal tract; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical hearing instruments; Medical instruments for percutaneous tracheostomy; Medical instruments for cutting tissue; Dissecting instruments for medical use; Cases fitted for medical instruments; Medical instruments for recording heart activity; Nanolaser therapy instruments for medical purposes; Medical instruments and devices, namely, external fixators; Medical instruments for use in performing biopsies; Medical instruments for analysing and identifying bacteria; Medical instruments for analyzing and identifying bacteria; Containers especially adapted for the disposal of medical instruments, syringes and other contaminated medical waste; Gynecological medical instruments for examining women's reproductive organs; Medical instruments, namely, biosensors for detecting infectious diseases; Medical instruments for interstitial thermotherapy of biological tissue; Medical hearing instruments and parts of such devices; Medical instruments and apparatus, namely, delivery apparatus for fibrin sealant; Medical apparatus, namely, invasive and non-invasive ventilation apparatus and instruments; Cases fitted for medical instruments and/or for use by doctors; Surgical and medical apparatus and instruments for use in orthopedic surgery; Medical apparatus and instruments for monitoring blood properties and respiratory events; Containers especially adapted for the disposal of medical instruments and syringes; Light emitting diode (LED) apparatus for lighting, incorporated into medical instruments; Surgical and medical apparatus and instruments for use in general surgery; Medical and surgical apparatus and instruments, namely, vertebral osteosynthesis staple-shaped apparatus and instruments; Medical apparatus and instruments for use in positron emission tomography (PET) imaging; Medical bags adapted for and sold with medical, surgical and veterinary instruments; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical and surgical apparatus and instruments for use in implantation of shoulder prostheses; Medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters; Medical apparatus and instruments for treating osteotraumatic injuries, degenerative bone diseases and joint diseases; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, and vital signs; Medical apparatus and instruments for treating osteoarthritis, osteoporosis, osteotraumatic injuries, degenerative bone diseases and joint diseases; Electro-surgical motors being part of surgical and medical apparatus and instruments for use in general surgery; Medical and surgical apparatus and instruments, namely, orthopedic fixation device used in orthopedic transplant and/or implant surgery; Medical apparatus and instruments, namely, a handheld ultrasound unit for cardiac diagnosis, screening and cardiovascular patient follow-up; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and recorded software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Medical apparatus and instruments for monitoring blood oxygen saturation, blood gas concentrations, vital signs and respiratory events, and downloadable software for recording, processing and transmitting medical data, for use therewith, sold as a unit; Light emitting diode (LED) devices for energy-efficient replacement of standard tungsten-filament lighting incorporated into hand-held medical instruments; Medical and surgical apparatus and instruments, namely, devices used in orthopedic surgery to position surgical instruments, implants and/or patients' limbs; Medical apparatus and instruments for use in positron emission tomography (PET) imaging used to monitor brain, heart and metabolic functions; Medical instruments for intraluminal emplacement of stents or of synthetic stent grafts, namely, stent or synthetic stent graft delivery systems; Medical devices, namely, tubing and valve assembly set and electromechanical fluidic instrument, and other similar or related devices, which process human red blood cells with clinical medical reagents for the purpose of converting blood groups for use in blood transfusions; Medical devices, namely, tubing and valve assembly set and electromechanical fluidic instrument, and other similar or related devices, which process human whole blood for the purpose of separating human blood components for use in blood transfusions and washing human red blood cells with clinical medical reagents for use in blood transfusions; Surgical apparatus and instruments for medical, dental or veterinary use; Medical supply organizer specially adapted for holding medical instruments and pharmaceuticals for use in pediatric resuscitationACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 5, 2026ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 13, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 13, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 7, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 15, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 15, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 15, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Sep 15, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 15, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
May 14, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 1, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Aug 26, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 26, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Aug 26, 2025CNSLSUSPENSION LETTER WRITTEN—
Aug 19, 2025DOCKASSIGNED TO EXAMINER—
Aug 5, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 19, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 19, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance